Treatment Module

Managing POTS

POTS is highly treatable. A stepwise, evidence-based approach addressing lifestyle first, then medication, achieves significant improvement in the majority of patients. The aim is functional recovery — not just symptom suppression.

Treatment Approach

Stepwise Treatment Strategy

Treatment should be personalised and stepwise. Non-pharmacological measures are the cornerstone of POTS management — many patients achieve significant improvement with lifestyle modification alone. Medication is additive, not a substitute for behavioural change.

1

Education, salt/fluid loading, sleep positioning

Always first
2

Physical counter-manoeuvres + compression garments

Add early
3

Structured exercise rehabilitation (Levine Protocol)

Cornerstone
4

Pharmacological treatment (subtype-guided)

If needed
5

Specialist referral / MDT management

Complex cases

Targets of Care

HR at 10 min standing< 120 bpm
HR rise on standing< 30 bpm
Symptom burdenCOMPASS-31 ↓
Daily stepsProgressive increase
Quality of lifeRAND-36 / SF-36 ↑

Review patients at 6–8 weeks. Most will show improvement with non-pharmacological measures alone. Do not rush to medication.

Non-Pharmacological

Lifestyle & Behavioural Measures

Education & Explanation

First Line
  • Explain POTS mechanism to patient — often very reassuring
  • Reassure: POTS is not life-threatening; most improve significantly
  • Empower patient with self-management strategies
  • Provide written resources (POTS UK, StopFainting)
  • Explain the postural component — why lying flat provides relief

Salt & Fluid Loading

First Line
  • Target fluid intake: 2–3 litres per day
  • Salt intake: 8–10g/day (liaise with dietitian)
  • Salt tablets (1–2g TDS with meals) if dietary increase insufficient
  • Electrolyte drinks (ORS/sports drinks) during activity
  • Avoid diuretics, alcohol, and excess caffeine
  • Contraindicated in hypertension or heart failure — check BP

Physical Counter-Manoeuvres

First Line
  • Leg crossing & tensing (reduces venous pooling acutely)
  • Squatting (immediate HR reduction)
  • Toe raises / calf pumping before standing
  • Bending forward from the waist
  • Teach patient to use these at symptom onset

Compression Garments

First Line
  • Full-length compression tights preferred over stockings alone
  • At least 30–40 mmHg compression
  • Abdominal binders helpful for abdominal pooling
  • Worn during waking hours
  • Stockings alone (knee-high) less effective

Exercise Rehabilitation

Key Intervention
  • Deconditioning worsens POTS — exercise is cornerstone of recovery
  • Start with recumbent/horizontal exercise: rowing, swimming, cycling
  • Avoid upright exercise initially (worsens symptoms)
  • Levine Protocol: structured 3-month recumbent reconditioning programme
  • Progress to upright exercise as tolerated
  • Target 30 min aerobic + 20 min resistance training, 3–5×/week
  • Enlist physiotherapist with POTS/dysautonomia experience

Sleep & Positional Strategies

Adjunctive
  • Elevate head of bed 10–15 cm (not just pillow — whole bed)
  • Reduces overnight diuresis and maintains volume
  • Avoid prolonged lying flat during the day
  • Regular sleep schedule; avoid sleep deprivation

Dietary Modifications

Adjunctive
  • Eat small, frequent meals rather than large ones
  • Avoid high-carbohydrate meals (splanchnic pooling)
  • Consider low-FODMAP if GI symptoms prominent
  • Gluten-free trial if coeliac antibodies positive
  • Limit alcohol — vasodilatory effect worsens POTS

The Levine Exercise Protocol

Developed at UT Southwestern, this 3-month structured reconditioning programme is the most evidence-supported intervention for POTS. It begins with horizontal exercise (rowing, recumbent cycling) and progressively moves to upright activity as tolerance builds.

Month 1

Horizontal Phase

Rowing, swimming, recumbent cycling 3×/week. Resistance 2×/week (lower body). 30 min per session.

Month 2

Transition Phase

Introduce upright cycling with back support. Increase to 4×/week. Add upper body resistance.

Month 3

Upright Phase

Walking, upright cycling, elliptical. 5×/week aerobic + 3×/week resistance. Build to full activity.

Pharmacological Treatment

Medication Options

Medication is additive to non-pharmacological measures. Subtype identification guides drug selection. Always start at the lowest dose.

Prescribing note: Several medications used in POTS are off-label. Discuss with patient and document consent. Clinical decisions must be based on individual patient circumstances.

DrugDoseMechanism & IndicationCautionsEvidence
Fludrocortisone
0.05–0.2 mg daily

Mineralocorticoid — increases sodium & water retention

Hypovolaemic POTS; inadequate response to salt/fluid

Monitor BP, potassium. Avoid in hypertension. Not in hyperadrenergic POTS.Moderate
Propranolol (low dose)
10–40 mg TDS/QDS

Non-selective beta-blocker — reduces HR on standing

Hyperadrenergic POTS; HR-dominant symptoms

Avoid in asthma. May worsen fatigue. Low dose only — high doses worsen symptoms.Moderate
Ivabradine
2.5–7.5 mg BD

If-channel blocker — selective sinus rate reduction

Tachycardia-dominant POTS; intolerance to beta-blockers

Contraindicated in acute HF, sick sinus, severe hepatic impairment. Off-label use.Moderate (growing evidence base)
Midodrine
2.5–10 mg TDS

Alpha-1 agonist — peripheral vasoconstriction, reduces venous pooling

Neuropathic POTS; orthostatic symptoms despite first-line treatment

Supine hypertension — do not take within 4 hours of lying down. Last dose before 6pm.Good
Pyridostigmine
30–60 mg BD–TDS

Acetylcholinesterase inhibitor — enhances autonomic ganglionic transmission

Neuropathic POTS; autoimmune POTS

GI side effects (nausea, diarrhoea). Avoid in asthma, bowel obstruction.Moderate
Clonidine
0.05–0.2 mg BD

Central alpha-2 agonist — reduces sympathetic outflow

Hyperadrenergic POTS specifically

Sedation, dry mouth. Rebound hypertension on abrupt withdrawal.Limited (specialist use)
SSRIs / SNRIs
Various

Serotonergic modulation of sympathetic tone; treat comorbid anxiety/depression

POTS with anxiety comorbidity; post-viral POTS

Monitor BP. Some SSRIs may worsen tachycardia initially.Limited
Low-dose Naltrexone
1.5–4.5 mg at night

Immunomodulatory; emerging evidence in autoimmune POTS

Post-COVID POTS; autoimmune POTS; specialist centre use

Off-label. Limited evidence. Avoid in opioid dependence.Emerging
Special Populations

POTS in Special Contexts

Post-COVID POTS

A distinct phenotype of POTS increasingly seen following COVID-19 infection. Onset typically 1–3 months post-infection. May involve autoimmune mechanisms (mast cell activation, autoantibodies). Standard POTS management applies; low-dose naltrexone or LDN being investigated. Most improve over 12–18 months.

POTS in hEDS

Hypermobile Ehlers-Danlos Syndrome co-occurs in 25–50% of POTS patients. Connective tissue laxity promotes venous pooling. Physiotherapy for joint stabilisation is paramount. Compression particularly important. Avoid high-impact exercise. Consider mast cell activation syndrome overlap.

POTS in Pregnancy

POTS often worsens in first trimester (vasodilation, increased HR) then may improve by third trimester. Avoid pharmacological treatment where possible. Increase salt and fluid intake. Compression safe. Midodrine and fludrocortisone should be used with caution — discuss with maternal medicine team.

Adolescent POTS

HR criterion is ≥40 bpm in under-18s. Puberty is a common trigger. Exercise reconditioning is highly effective. School accommodations often needed. Avoid medicalising normal adolescent variation. Most resolve by early adulthood. Parental involvement in education essential.

Follow-Up

Monitoring & Review

6–8 weeks

  • Repeat active stand test
  • Symptom questionnaire (COMPASS-31)
  • Review fluid/salt compliance
  • Exercise programme progress
  • Assess for medication side effects

3 months

  • Formal exercise tolerance assessment
  • Review subtype classification
  • Adjust medications if indicated
  • School/work accommodation review
  • Mental health screening

6–12 months

  • Assess for comorbidities (hEDS, MCAS)
  • Consider specialist referral if refractory
  • Long-term exercise maintenance plan
  • Driving assessment if applicable
  • Review and discharge if stable

Prognosis: With appropriate management, the majority of POTS patients achieve meaningful functional improvement within 12 months. Adolescents have the best prognosis — many enter remission by early adulthood. Post-COVID POTS frequently improves over 12–18 months.

Ready to train further?

Explore the full physician training programme — case-based learning, video modules, and clinical pearls from Dr Boon Lim.

Physician Training